Irie K, Yanai Y, Oie K, Ishizawa J, Nakagawa Y, Ohigashi H, Wender P A, Kikkawa U
Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Japan.
Bioorg Med Chem. 1997 Aug;5(8):1725-37. doi: 10.1016/s0968-0896(97)00116-8.
Protein kinase C (PKC) is a key enzyme family involved in cellular signal transduction. The binding of endogenous diacyl glycerol (DAG) to the cysteine-rich domain (CRD) of PKC is associated with normal cell signaling and function. In contrast, the binding of exogenous phorbol esters to the CRD of PKC is considered to be a key initiating event in tumor promotion. Conventional PKC isozymes (PKC alpha, beta I, beta II, and gamma) contain two CRDs, both of which are candidates for the phorbol ester binding site. In order to elucidate the binding requirements of phorbol esters and to obtain information on the phorbol ester binding site in native PKC gamma, several key chemical characteristics of the first and the second CRDs consisting of ca. 50 amino acids of rat PKC gamma (gamma-CRD1 and gamma-CRD2) were examined. In the presence of Zn2+ and phosphatidylserine (PS), both CRDs gave similar Kd values (65.3 nM for gamma-CRD1, 44.1 nM for gamma-CRD2) in phorbol 12,13-dibutyrate (PDBu) binding assays. In comparison, the binding affinity of PDBu for native rat PKC gamma was found to be 6.8 nM. Zn2+ was shown to play an important role in the folding and PDBu binding of both CRDs. A Zn(2+)-induced conformational change was observed for the first time by CD spectroscopic analysis of the complexed and uncomplexed CRDs. Relative to the pronounced Zn2+ effect, most divalent first row transition metal ions along with Ca2+, Mg2+, and Al3+ were ineffective in folding either CRD. Notably, however, Co2+ exhibited a gamma-CRD1-selective effect, suggesting that metal ions, not unlike extensively used organic probes, might also become effective tools for controlling isozyme selective activation of PKC. Moreover, group Ib (Cu2+ and Ag+) and group IIb element ions other than Zn2+ (Cd2+ and Hg2+) were found to abolish PDBu binding of both CRDs. Importantly, these inhibitory effects of Cu2+, Ag+, and Cd2+, and Hg2+ were also observed with native PKC gamma. These results indicate that recent reports on the modulation of conventional PKC by heavy metal ions could be explained by their coordination to the CRDs. While the similar affinities of gamma-CRD1 and gamma-CRD2 for PDBu suggest that either site qualifies as the PDBu binding site, new molecular probes of these CRD3 have now been identified that provide information on the preferred site. These novel ligands (5a and 5b) were synthesized by aza-Claisen rearrangement of (-)-N13-desmethyl-N13-allylindolactam-G (4). These compounds did not significantly affect the specific PDBu binding of gamma-CRD1 but did inhibit that of gamma-CRD2 with similar potency to (-)-indolactam-V. Moreover, these new probes did not significantly inhibit the PDBu binding of native PKC gamma. (-)-Indolactam-V itself bound almost equally to gamma-CRD1, gamma-CRD2, and native PKC gamma. These results suggest that the major PDBu binding site in native PKC gamma is the first CRD, not the second CRD, unlike the novel PKCs.
蛋白激酶C(PKC)是参与细胞信号转导的关键酶家族。内源性二酰基甘油(DAG)与PKC富含半胱氨酸的结构域(CRD)的结合与正常细胞信号传导和功能相关。相比之下,外源性佛波酯与PKC的CRD结合被认为是肿瘤促进中的关键起始事件。传统的PKC同工酶(PKCα、βI、βII和γ)含有两个CRD,两者都是佛波酯结合位点的候选者。为了阐明佛波酯的结合要求并获得关于天然PKCγ中佛波酯结合位点的信息,研究了由约50个大鼠PKCγ氨基酸组成的第一个和第二个CRD(γ-CRD1和γ-CRD2)的几个关键化学特征。在存在Zn2+和磷脂酰丝氨酸(PS)的情况下,在佛波醇12,13-二丁酸酯(PDBu)结合试验中,两个CRD给出了相似的Kd值(γ-CRD1为65.3 nM,γ-CRD2为44.1 nM)。相比之下,发现PDBu对天然大鼠PKCγ的结合亲和力为6.8 nM。结果表明,Zn2+在两个CRD的折叠和PDBu结合中起重要作用。通过对复合和未复合CRD的CD光谱分析首次观察到Zn(2+)诱导的构象变化。相对于明显的Zn2+效应,大多数二价第一排过渡金属离子以及Ca2+、Mg2+和Al3+在折叠任何一个CRD时均无效。然而,值得注意的是,Co2+表现出γ-CRD1选择性效应,表明金属离子与广泛使用的有机探针不同,也可能成为控制PKC同工酶选择性激活的有效工具。此外,发现除Zn2+(Cd2+和Hg2+)之外的Ib族(Cu2+和Ag+)和IIb族元素离子会消除两个CRD的PDBu结合。重要的是,在天然PKCγ中也观察到了Cu2+、Ag+、Cd2+和Hg2+的这些抑制作用。这些结果表明,最近关于重金属离子对传统PKC调节的报道可以通过它们与CRD的配位来解释。虽然γ-CRD1和γ-CRD2对PDBu的亲和力相似,表明任何一个位点都可作为PDBu结合位点,但现在已经鉴定出这些CRD3的新分子探针,它们提供了关于首选位点的信息。这些新型配体(5a和5b)是通过(-)-N13-去甲基-N13-烯丙基吲哚内酰胺-G(4)的氮杂克莱森重排合成的。这些化合物对γ-CRD1的特异性PDBu结合没有显著影响,但确实以与(-)-吲哚内酰胺-V相似的效力抑制γ-CRD2的结合。此外,这些新探针没有显著抑制天然PKCγ的PDBu结合。(-)-吲哚内酰胺-V本身与γ-CRD1、γ-CRD2和天然PKCγ的结合几乎相同。这些结果表明,与新型PKC不同,天然PKCγ中的主要PDBu结合位点是第一个CRD,而不是第二个CRD。